Cardinal Capital Management lessened its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 1.5% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 29,084 shares of the medical instruments supplier’s stock after selling 443 shares during the quarter. Becton, Dickinson and comprises 1.8% of Cardinal Capital Management’s portfolio, making the stock its 10th largest holding. Cardinal Capital Management’s holdings in Becton, Dickinson and were worth $5,699,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of BDX. BlackRock Inc. grew its holdings in Becton, Dickinson and by 2,427.8% during the 1st quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock valued at $3,034,470,000 after buying an additional 15,887,611 shares in the last quarter. Koch Industries Inc. grew its holdings in Becton, Dickinson and by 45,268.7% during the 2nd quarter. Koch Industries Inc. now owns 1,398,264 shares of the medical instruments supplier’s stock valued at $1,391,000 after buying an additional 1,395,182 shares in the last quarter. Vanguard Group Inc. grew its holdings in Becton, Dickinson and by 8.5% during the 2nd quarter. Vanguard Group Inc. now owns 17,255,948 shares of the medical instruments supplier’s stock valued at $3,366,809,000 after buying an additional 1,353,780 shares in the last quarter. Winslow Capital Management LLC purchased a new position in Becton, Dickinson and during the 2nd quarter valued at about $225,164,000. Finally, Janus Henderson Group PLC grew its holdings in Becton, Dickinson and by 1,265.9% during the 2nd quarter. Janus Henderson Group PLC now owns 1,210,837 shares of the medical instruments supplier’s stock valued at $236,245,000 after buying an additional 1,122,191 shares in the last quarter. 86.70% of the stock is owned by institutional investors and hedge funds.

In other Becton, Dickinson and news, insider Ellen R. Strahlman sold 9,283 shares of the business’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $198.21, for a total value of $1,839,983.43. Following the completion of the sale, the insider now owns 26,638 shares in the company, valued at $5,279,917.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary M. Cohen sold 15,512 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $203.77, for a total value of $3,160,880.24. Following the completion of the sale, the insider now owns 95,781 shares of the company’s stock, valued at approximately $19,517,294.37. The disclosure for this sale can be found here. Insiders sold a total of 75,904 shares of company stock valued at $15,242,688 in the last 90 days. 1.40% of the stock is currently owned by corporate insiders.

A number of brokerages have recently issued reports on BDX. Stifel Nicolaus reiterated a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. BidaskClub downgraded Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Bank of America Corporation reiterated a “buy” rating and set a $225.00 price target (up previously from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 price target for the company in a research report on Monday, July 17th. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $213.00 price target on shares of Becton, Dickinson and in a research report on Tuesday, September 12th. Five equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $211.94.

Shares of Becton, Dickinson and Company (NYSE BDX) opened at $224.41 on Friday. The company has a debt-to-equity ratio of 1.48, a current ratio of 5.56 and a quick ratio of 5.01. The stock has a market capitalization of $50.98 billion, a price-to-earnings ratio of 23.61, a P/E/G ratio of 1.77 and a beta of 1.04.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.37 by $0.03. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.14 billion. Becton, Dickinson and had a return on equity of 22.51% and a net margin of 8.52%. Becton, Dickinson and’s quarterly revenue was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.12 EPS. equities analysts forecast that Becton, Dickinson and Company will post 10.65 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This article was published by Watch List News and is the property of of Watch List News. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://www.watchlistnews.com/cardinal-capital-management-sells-443-shares-of-becton-dickinson-and-company-bdx/1677709.html.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.